These compounds may interact with:
5-hydroxytryptamine receptor 2C
Potentially involved in: carcinoma; schizophrenia; obsessive-compulsive disorder; bipolar disorder; major depressive disorder; migraine; obesity; premature ejaculation; generalized anxiety disorder; alcohol dependence; panic disorder; seasonal affective disorder; substance abuse; lingual-facial-buccal dyskinesia; prader-willi syndrome; eating disorder; attention deficit hyperactivity disorder; high pressure neurological syndrome; parkinson's disease; personality disorder
Disease data sourced from Pharos.